Circulating Tumor Cells And CEA Levels Help Predict Survival in Metastatic CRC

Circulating tumor cells (rare cells from a cancerous tumor that appear in the bloodstream) can help predict how a person with metastatic colorectal cancer (mCRC) might do over time. A study published in the October 2012 Annals of Oncology compared levels of CTCs with levels of CEA (carcinoembryonic antigen) to see how the two tests compared…  Read More

Colorectal Cancer News in Brief: May 1

A new type of drug was successful in helping patients with cancer cachexia regain muscle and strength, and counting circulating tumor cells helped predict survival for people with advanced colorectal cancer. Free colonoscopies are available through a Connecticut program, the FDA and FTC warn the public to be wary of websites or ads promising treatments for…  Read More

Circulating Tumor Cells Provide Information about Prognosis

The number of cancer tumor cells circulating in the bloodstream can provide information about prognosis and survival for people with metastatic colorectal cancer.  Measuring circulating tumor cells before beginning a treatment and then during treatment can help doctors decide if the therapy is working or whether cancer is getting worse. Tumor cells can be found in…  Read More